Yogesh N. V. Reddy, MD, MSc; David M. Kaye, MBBS, PhD; M. Louis Handoko, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(9):891-899. doi:10.1001/jamacardio.2022.1916
This case-control study evaluates the performance of the H2FPEF and HFA-PEFF algorithms to diagnose heart failure with preserved ejection fraction among ambulatory patients with dyspnea.
Vardhman Jain, MD; Abdul Mannan Khan Minhas, MD; Alanna A. Morris, MD, MSc; et al.
free access
JAMA Cardiol. 2022;7(9):900-904. doi:10.1001/jamacardio.2022.2213
This cohort study assesses trends in heart failure鈥搑elated mortality in Black, Hispanic, and White young adults.
Tariq Ahmad, MD, MPH; Nihar R. Desai, MD, MPH; Yu Yamamoto, MS; et al.
free access
has audio
JAMA Cardiol. 2022;7(9):905-912. doi:10.1001/jamacardio.2022.2496
This randomized clinical trial investigates if the provision of prognostic information regarding patients with heart failure to clinicians results in improved decision-making about treatment initiation and intensity, appropriate end-of-life care, and reduction in hospitalization or death rates.
-
Podcast:
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
-
Invited Commentary
Improving Quality Improvement鈥擣rom Aspiration Toward Empiricism
Andrew S. Oseran, MD, MBA; Rishi K. Wadhera, MD, MPP, MPhil
JAMA Cardiol
-
Podcast:
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
Kazuma Oyama, MD, MPH, PhD; Itamar Raz, MD; Avivit Cahn, MD; et al.
free access
JAMA Cardiol. 2022;7(9):914-923. doi:10.1001/jamacardio.2022.2006
This randomized clinical trial analyzes data according to use of common cardiovascular medications to determine the cardiorenal efficacy and safety of dapagliflozin in patients with type 2 diabetes.
Go Hashimoto, MD; Maurice Enriquez-Sarano, MD; Larissa I. Stanberry, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(9):924-933. doi:10.1001/jamacardio.2022.2108
This cohort study compares left ventricular remodeling measurements by cardiac magnetic resonance and echocardiography between patients with and without heart failure symptoms.
-
Podcast:
Association of LV Remodeling Assessment by CMR With Outcomes in Patients With Chronic Aortic Regurgitation
Dhaval Kolte, MD, PhD; Bhaskar Bhardwaj, MD; Michael Lu, PhD; et al.
free access
JAMA Cardiol. 2022;7(9):934-944. doi:10.1001/jamacardio.2022.2222
This cohort study examines the association between early left ventricular ejection fraction (LVEF) improvement and 5-year clinical outcomes after transfemoral transcatheter aortic valve replacement (TAVR) in high- or intermediate-risk patients with symptomatic severe aortic stenosis and LVEF less than 50%.
Angela Lowenstern, MD; Anna Hung, PhD; Pratik Manandhar, MS; et al.
free access
JAMA Cardiol. 2022;7(9):945-952. doi:10.1001/jamacardio.2022.2608
This cohort study evaluates the association between Centers for Medicare & Medicaid Services transcatheter aortic valve replacement (TAVR) reimbursement rates with embolic protection device (EPD) use.
Arjen J. Cupido, MD; Laurens F. Reeskamp, MD, PhD; Aroon D. Hingorani, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(9):955-964. doi:10.1001/jamacardio.2022.2333
This cohort study examines data for participants in the UK Biobank to determine associations of a combined reduction of CETP and PCSK9 concentrations with plasma lipid levels and such clinical outcomes as risk of coronary artery disease and age-related macula degeneration.
Lisa M. Dellefave-Castillo, MS; Allison L. Cirino, MS; Thomas E. Callis, PhD; et al.
open access
JAMA Cardiol. 2022;7(9):966-974. doi:10.1001/jamacardio.2022.2455
This cohort study assesses the diagnostic yield and clinical management implications of combined cardiomyopathy and arrhythmia genetic testing among patients with a suspected genetic cardiomyopathy or arrhythmia.
-
Editorial
Genetic Testing Panels in Inherited Cardiac Diseases鈥擠oes Size Really Matter?
Julia Isbister, MBBS; Luciana Sacilotto, MD, PhD; Christopher Semsarian, MBBS, PhD, MPH
JAMA Cardiol